Significance of Histamine in Enhancement of Contractile Tension During the Atrial Anaphylaxis by Yasuda Mitsunori
Acta med. nagasaki. 9 : 200-211
Significance of Histamine in Enhancement of Contractile 
     Tension During the Atrial Anaphylaxis*1
Mitsunori YASUDA*2
Department of Pharmacology, 
Nagasaki University School of 
    Medicine, Nagasaki
Received for publication, March 5, 1965
   Although it has been generally considered that histamine plays a princi-
pal role in the anaphylactic reaction, no hypothesis to explain it has been 
confirmed experimentally. This investigation was attempted to re-examine 
the significance of histamine in the anaphylactically induced dynamic 
responses. The results obtained are as follows : Histamine was released 
from the isolated atrial and ventricular muscle of sensitized guinea pigs in 
anaphylaxis. Numbers of mast cells in the ventricular muscle are incomp-
arablly fewer than in the epi-and pericardium. Therefore histamine released 
during anaphylaxis would partially come from the muscle cell, that is to 
suppose that the cardiac muscle cell is sensitized by antigen. Metabolic 
inhibitors apparently depressed histamine release in atrial anaphylaxis. 
Monoiodoacetate (2.15 mM) inhibited histamine release almost completely, 
but provoked a dynamic response of the atrial anaphylaxis. Sodium arsenite 
(3.85 mM or more) inhibited completely the dynamic response of the atrial 
anaphylaxis, while histamine release was not completely reduced by 
arsenite. These results indicate that released histamine may not be 
responsible to dynamic responses in the atrial anaphylaxis.
   It was presented by H. H. DALE and P. P. LAIDLAW 6) that the 
antigen-atibody union in the body causes liberation of histamine which 
participates in the contractile responses, the so called histamine theory7>. 
The theory has been supported by many workers 1)2)4)5)9)26) mostly from 
agreement in amounts of released histamine and its comparable biolog-
ical activities or from similarity of pharmacodynamic action of hista-
mine and of anaphylactic reaction. On the other hand, K NAKAMURA23) 
has made a versatile study on the mode of anaphylactic reaction and 
claimed the importance of acetylcholine instead of histamine because they
*1 A part of this work was presented at the 17th regional meeting of the Seinan 
   area of the Japanese Pharmacological Society in November 1964.
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observed closer similarity in acetylcholine. 
    Y. NAKAZAWA24) and K. GREEF11) reported the anaphylactic reaction 
in the atrial preparation of guinea pig, the increase of contractile force 
and beat rate. F. KIHARA15) have shown that various antihista minicagents 
did not inhibit atrial anaphylaxis, and he considered that released histamine 
might not be a substance principally responsible to the anaphylactic 
reaction in the atrium. The other paper from our laboratory also criticized 
the role of acetylcholine, noradrenaline and serotonin in atrial dynamic 
anaphylaxis16)25) 
    Recentry, Y. NAKAZAWA and A. UEN027) reported that the configur-
ation of intracellular action potential of a single proper atrial fiber of 
guinea pig during anaphylaxis changed similarly as in administration of 
histamine. M. KIDO14) also observed the changes in the action potential's 
pattern of specialized fiber in guinea pigs during anaphylaxis in vitro. 
   An attempt of the present paper was made to evaluate significance 
of accelerating effects of histamin on contractile response and beat rate 
in the atrial anaphylaxis in vitro. For this purpose, the. actual contents 
of histamine in the atrium and the amounts released during anaphylaxis 
were measured. And the pharmacodynamic response of histamine was 
investigated in the concentration which might be released from the tissue 
into the nutrient solution. 
                MATERIALS AND METHODS 
   Male and female guinea pigs weighing between 200g to 300g were 
used throughout the experiment. Passive sensitization of guinea pigs 
against egg albumin was mainly carried out by intravenous injection 
of anti-egg-albumin rabbit serum having 1 x 128 to 1 x 256 antibody titre, 
0.3 ml per 100 g body weight, 24 hours prior to the experiment, and 
active sensitizations were done by parental injection of 2 ml of 2 % egg 
albumin solution containing potassium alum at 1 % level and neutralized 
with sodium carbonate divided into half. The one was injected intra-
peritoneally and the remainder subcutaneously, 3 to 4 weeks prior to 
the experiment. 
   The atria were quickly removed from exsanguinated guinea pigs 
and placed in 32 °C bath containing 20 ml of Ringer's solution composed 
NaCI 9.0 g, KCl 0.42 g, CaC12 0.32 g, NaHCO3 0.5 g and glucose 1.0 g per 
1 liter of distilled water, and aerated with oxygen through a glass filter at 
the bottom. And recording of atrial contraction was made in isometric 
condition with the aid of Shinkoh unbonded strain gauge transducer 
UL-50-120 or UL-10-120 in connection with a conventional dynamic 
strain amplifier and pen recorder. 
   Quantitative determination of histamine in the cardiac tissue was 
carried out by using the material freshly isolated and survived in oxygen-
 ated 37'C Ringer's solution. For determination of released histamine,
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the bath solution was changed repeatedly several times prior to the 
experiment in order to reduce previous contamination by spontaneously 
released histamine. Histamine was extracted by the method of CODE4) 
and the amount of histamine was determined biologically in a piece of 
guinea pig ileum at 32'C by comparing with isometric contraction of 
known amount of histamine. 
                     RESULTS 
   1. Contents of histamine in the isolated atrium and its release by 
       the specific antigen 
   The contents of histamine in non-sensitized guinea pig atria were 
varied in considerable wide range as shown in Table 1- A, i. e., from 
3.91 ug/g to 12.42 ug/g, and the average of content was 8.64 ug/g. 10 
minutes after addition of eggalbumine at 0.02 % level, the amounts of 
histamine in the bath solution were estimated. The values were varied 
from below sensitized to 0.14 ug/g, and 0.05 ug/g in average. The 
ratio of the amount found in the bath solution to tissue histamine was 
0.58 % on the average. 
   Histamine content in sensitized guinea pig's atrium was 8.17 ug/g 
and the amount released from the sensitized atrium was 2.23 ug/g as 
 shown in Table 1- B. The largest value is 6.00 ug/g/20ml bath in
         Table 1 
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which 0.03 ug/ml is contained. The ratio of anaphylactic ally released 
histamine to tissue histamine is 27.3% in average. 
   Although the above values fluctuate largely, average values of 
histamine contents in both non-sensitized and sensitized atria show no 
significant difference. However, it is clearly demonstrated that hista-
mine amounts released from the guinea pig atrium during anaphylaxis 
are much more than those from normal one. 
   2. Amounts of histamine released from ventricular muscle and 
       comparison with those from epi-and pericardium in sensitized 
      guinea pigs 
   Amounts of histamine released from the chopped ventricular muscle 
layer and epi-and pericardium were also determined as shown in Table 
2. The average value appeared as 0.41 ug/g in the myocardium and 
0.98 ug/g in the eip-and pericardium. The ratio of the former to the 
latter is 41.8%.
   For the purpose of a microscopic 
observation of mast cells, the car-
diac tissue was fixed with a solution 
of lead subacetate in acidified alcohol 
and was stained with toluidine blue 
20)21)      Numbers of mast cells in both 
the epi-and pericardium and the 
myocardium were calculated micro-
scopically. There was observed 
much more mast cells in the epi-
and pericardium than in the myoca-
rdium (Fig. 1). 
    Although histamine amount 
released in the myocardium is 41.8% 
of that in the epi-and pericardium, 
numbers of mast cells in the myo-
cardium are incomparablly fewer 
than those in the epi-and pericar-
dium. This discrepancy suggests 
that the muscle cell would release 
histamine during anaphylaxis. 
   3. Effects of metabolic inhibi-
       tors on the anaphylactic 
        histamine release
      Table 2 
Comparison of histamine 
release by egg albumin 



















0.41 (a) 0.98 (b)
a/b x 100=41.8%
   Monoiodoacetate13)18)29), sodium malonate29), phenobarbital3), 2,4-
dinitropheno113)17)18)22)28)29), sodium fluoridel3'18), sodium arsenite10) 
and potassium cyanide 18)29) were used at such concentrations as that 
dynamic responses in the atrial anaphylaxis were affected, After atria
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Fig. 1. Mast cells having metachromatic granules in epicardium 
          and in myocardium of sensitized guinea pig (toluidine 
         blue stain). 
          A : Note numerous mast cells distributed though the 
                 epicardium, approx. X 150 
          B : Note few mast cells distributed though the myoca-
                 rdium, approx. X 150
were treated with these inhibitors for 10 minutes, they were removed 
in Ringer's solution containing antigen (0.02%) and immersed for 10 
minutes until released histamine was measured. 
   Monoiodoacetate : When the atrium was treated with 0.54 mM mono-
iodoacetate, anaphylactically released histamine was 10.2% of the tissue 
content. This value is much less than that in the control value (Table 
1-B). The histamine release was inhibited by mono iodoacetate. The 
higher the drug concentrations, the stronger this inhibition appeared 
(Table 3-1),
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       Table 3 - 1 
Influence of some Metabolic 
inhibitors on anaphylactic 
histamine release
      Table 3 2 . 
Influence of some metabolic 
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   Sodium malonate : This agent did not inhibit the histamine release 
at 10mM concentration but decreased it at 100 mM (Table 3-1). 
   Phenobarbital : Treatment with phenobarbital at 1.97 mM showed 
a little inhibition of the histamine'release. But it was inhibited markedly 
at 19.7 mM (Table 3 -1)
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   2,4 - dinitrophenol : The 
histamine release was . increased 
by low concentration (0. 0054mM) 
of 2, 4 -dinitrophenol . But at hig-
her concentrations. (0.054 mM or 
more) it caused a marked inhibi-
tion (Table 3-2). It is noticable 
that 2, 4-dinitrophenol plays dip-
hasic.attitude against anaphylactic 
histamine release. 
   Sodium. fluoride : Although 
no change in the histamine release 
was observed at 0.95 mM, the 
release was inhibited by this agent 
at 4.76 mM or more (Table 3 - 2). 
   Sodum arsenite : The hista-
mine release was inhibited by this 
agent at concentration of 3.85 mM 
or more (Table 3-3). 
   Potassium cyanide : This 
caused also marked inhibition of 
the histamine release at concentr-
ations over 0.77 mM (Table 3-3). 
   As above mentioned, the me-
tabolic inhibitors decreased the 
histamine release in the atrial 
tissue during anaphylaxis. The 
more the concentrations, the more 
strongly the inhibition appeared. 
However, 2,4 - dinitrophenol in-
creased only at low concentra-
tion the histamine release as sho-
wing in Table 4.
       Table 3 - 3 
Influence of some metabrlic 
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aver. 0.33 11.54 2.9
1.17 8.
0.63 8.1
   4. Relationship between released histamine and anaphylactic ally 
      induced dynamic responses in the atrium 
   a) Significance of histamine in dynamic responses during the atrial 
      anaphylaxis 
   It is known already that the atrium isolated from a sensitized 
guinea pig responds always with acceleration of beat rate and enhance-
ment of contractile tension, and the antigen causes the similar dynamic 
action as histamine. It is probable that the dynamic response of atrial 
anaphylaxis is due to released histamine. As histamine released during 
anaphylaxis amounts to 0.03 ug,-'ml at the largest, as above mentioned,
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                         Table 4 
         Influence of metabolic inhibitors on anaphylactic 
          histamine release
the same amount of histamine was added into bath in order to observe 
how responsible for the atrial preparation. However, no change occured 
in contractile tension and beat rate. This result':., indicates that the 
amount of histamine released from the atrium during anaphylaxis is 
not enough to cause a similar dynamic response as in the atrial 
anaphylaxis. 
   b) Influences of metabolic inhibitors on the dynamic response in 
      the atrial anaphylaxis 
   The metabolic inhibitors in higher concentrations inhibited not only 
anaphylactic release of histamine markedly, but the normal atrial move-
ment completely. The dynamic response of the sensitized atrium pretre-
ated with the inhibitor was not evoked wholly by the antigen as well as 
histamine 10 pg/ml and adrenaline 1 pg/ml, but in lower concentrations 
they did not inhibited the dynamic responses. 
   Monoiodoacetate (2.15 mM) inhibited almost completely the hista-
mine release during anaphylaxis and depressed contractile tension of 
the atrium within 10 minutes, while the dynamic response evoked by 
the antigen was demonstrated as shown in Fig. 2. After pretreatment 
with sodium arsenite (15.40 mM) application of the antigen to the
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Fig. 2. Anaphylactically induced dynamic response after 
          pretreatment with monoiodoacetate (2.15 mM). 
          AL : Administration of egg albumin (0.02 %).
Fig. 3. Anaphylactically induced dynamic response after 
          pretreatmemt with sodium arsenite (3.85 mM). 
         AL : Administration of egg albumin (0.02 %). 
        H : Administration of histamine (1 ug/ml).
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atrium caused no anaphylactic response at all, and neither histamine 
(10 pg/ml) nor adrenaline (1 pg/ml) caused any response. Although 
sodium arsenite at lower concentration (7.70 mM) inhibited both the 
histamine release and dynamic response in the atrial anaphylaxis it 
did not inhibit the response of histamine on the atrial contraction. In a 
low concentration (3.85 mM) the histamine release was decreased to 
one third, but the dynamic response in the anaphylaxis was inhibited 
completely as shown in Fig. 3. 
   The results clearly indicate that released histamine is not essential 
to the dynamic response of anaphylaxis of the atrium. 
                    DISCUSSION 
   It has been well known among many investigators" M that histamine 
is released from living tissue during anaphylaxis. In this experiments the 
amount of histamine released during anaphylaxis in sensitized guinea 
pig atrium in vitro is 2.23 ug/g on the average, which is much more 
than in non-sensitized one (0.05 ug/g). Thus, histamine is liberated by 
the anaphylactic reaction from the isolated atrium of guinea pig. 
   On the ocher hand, histamine released from the ventricular muscle 
of sensitized guinea pigs is about half of that from the epi-and pericar-
dium. As it has been already known that histamine released in living 
tissues comes from mast cells, numbers of mast cells were calculated 
microscopically in the cardiac tissues. The mast cells in the myocardium 
are incomparably fewer than those in the epi-and pericardium. Therefore, 
it is presumed that histamine released during anaphylaxis originate 
partially from the muscle cell, and antigen-antibody reaction would 
occur in cardiac muscle as well as plain muscle. 
   The metabolic inhibitors in .a certain concentration or more inhibited 
not only anaphylactic release of histamine markedly but normal atrial 
movement completely. Concerning metabotic inhibitors and anaphylaxis, 
J. L. MONGAR & H. O. SCHILD18)19) and H. YAMASAKI29) reported the 
diminution of histamine release by metabolic inhibitors and they pointed 
out that histamine release from the lung of guinea pigs during anaphy-
laxis was related with enzymic systems. It is of interest in this experi-
ment that 2, 4 - dinitrophenol - at very . low concentration (0.0054 mM ) 
increases the anaphylactic histamine release from the atrium, in which 
oxydative phosphylation might be accelerated 13'1"22'. 
   Monoiodoacetate (2.15 mM) inhibits almost completely the anaphy-
lactic . histamine release, while the dynamic response of the atrium is 
obviously evoked by the antigen. On the contray, the treatment with 
sodium arsenite (3.85 mM or more) inhibits 'the dynamic response in 
the anaphylactic reaction, but the histamine release during anaphylaxis 
is not completely reduced. These results indicate that released histamine 
has no close relation with dynamic response of the sensitized atrium
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during anaphylaxis. H. H. DALE in 19508) has postulated a speculation 
that an intrinsic liberation of histamine would occur if the reacting 
cell should encounter an antigen to which .it had itself become sensitized, 
and this might be the case in the allergic reaction of some tracts of 
plain muscle. On the other hand, it has been reported that the anaphy-
lactic reactions of the atrium15' and the ileum12)30 of sensitized guinea 
pigs are not inhibited by pretreatment with various antihistaminics. 
   From above results and studies in our laboratory it is considered 
that in the cardiac anaphylaxis not only mast cells liberate histamine 
reaching the reacting cell, but an intrinsic histamine might play a 
role of the dynamic response of anaphylaxis, or antigen-antibody 
reaction on the cell surface might change the membrane functions as 
Y. NAKAZAWA and A. UENO have pointed out27). 
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